# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000875045-17-000026
Filing Date
2017-10-24
Accepted
2017-10-24 07:24:35
Documents
3
Period of Report
2017-10-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | q32017earnings8-k.htm | 8-K | 17957
2 | EXHIBIT 99.1 | q32017pressrelease.htm | EX-99.1 | 565812
3 |  | biogenlogostandarda11.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-17-000026.txt |  | 1606219

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 171149947
SIC: 2836 Biological Products, (No Diagnostic Substances)